• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    British Journal of Radiology

    British Journal of Radiology

    JournalISSN 0007-1285eISSN 1748-880X中科院 医学 4区

    年发文量

    研究主题

    论文(30886)

    排序
    1Construction and Validation of a Prediction Model for TACE Resistance in Hepatocellular Carcinoma Based on Contrast-Enhanced Ultrasound Radiomics
    Zhibin Wu, Lutan Yan, Lin Zhou, Xiaoli Shi,Xiaohui Wang

    Abstract Objective To construct and validate a contrast-enhanced ultrasound (CEUS) radiomics-clinical model for predicting transarterial chemoembolization (TACE) resistance in hepatocellular carcinoma (HCC). Methods A total of 168 HCC patients who underwent CEUS on two vendor platforms (Philips E9 and GE Logiq E95) were split into a training set (n = 118) and an internal validation set (n = 50), with an additional 80 patients forming an external validation cohort. For each patient, 2D regions of interest were manually delineated on the largest cross-sectional slice of each CEUS phase. Radiomic features were extracted and screened by LASSO regression; the twelve retained features were linearly combined into a single Rad-score. The Rad-score and three prespecified clinical risk factors (tumor size, Child-Pugh class, AFP) confirmed by multivariate analysis were combined into a parsimonious logistic regression (LR) model with four predictors in total. Performance was assessed by ROC curve, calibration curve, decision curve analysis (DCA), subgroup analysis, and prospective validation. Results The combined model had AUCs of 0.895, 0.891 and 0.846 in three sets, with subgroup AUCs >0.86. Prospective validation showed TACE plus sorafenib improved 6-month response rate from 26.7% to 53.3% for high-risk patients. Conclusion The CEUS radiomics-clinical model accurately predicts TACE resistance, guiding individualized HCC treatment. Advances in Knowledge This model integrates CEUS multi-phase radiomics and clinical factors, outperforming single clinical/radiomic models. Strict multi-step screening and comprehensive validation avoid data leakage, ensuring robust prediction and clinical translatability.

    2026
    引用
    AI阅读
    加入学术空间
    2Beyond the Screening Paradigm: Why NHS Symptomatic Breast Services Require Bespoke AI Monitoring Parameters.
    Harshita Agarwal, Gaurav Jyoti Bansal
    2026
    引用
    AI阅读
    加入学术空间
    3Dosimetry for Radioembolization of Liver Metastases: Essential Knowledge for Interventional Radiologists.
    Charlotte C I Schneider, Arthur J A T Braat, Sanne M A Jansen, Maaike Dotinga, Kenneth F M Hergaarden, Regina G H Beets-Tan,Tarik R Baetens,Elisabeth G Klompenhouwer, Belinda J de Wit-van der Veen

    Abstract: In transarterial radioembolization (TARE) for liver metastases, dosimetry is essential to optimize therapeutic response while minimizing toxicity. Dose planning or pre-treatment dosimetry have evolved from empirical and single-compartment models to multi-compartment approaches, leading to improved tumour response and overall survival. More recently, voxel-based dosimetry has emerged as an advanced technique that provides high-resolution spatial dose mapping. Dose verification or post-treatment dosimetry using post-treatment imaging is essential for establishing dose-response relationships and defining clinically relevant dose thresholds. Even when such thresholds are proposed, their translation into clinical practice is challenging due to the numerous uncertainties introduced throughout the radioembolization workflow. Several physical and biological factors, including the effects of microsphere density remain insufficiently understood, making it difficult to determine their true impact on treatment outcomes. Collectively, these challenges underscore the need for standardized dosimetric methodologies and more robust evidence to enable reliable, personalized dose planning and verification, ultimately improving outcomes and expand the indications of radioembolization for liver metastasis.

    2026
    引用
    AI阅读
    加入学术空间
    4Comparative Performance of Contrast-enhanced Versus Abbreviated Non-contrast MR Enterography in Crohn Disease Evaluation: a Retrospective Study.
    Arvin Arian, Saeed Mohammadzadeh, Alireza Farahani,Madjid Shakiba, Mahdi Nowruzi, Peyman Kamali Hakim, Sina Delazar,Fahimeh Zeinalkhani

    Abstract Objectives In this study, we compared full protocol MR enterography (including contrast-enhanced images) and modified non-contrast protocol in assessment of CD activity. Material and method In this retrospective cross-sectional study, we included 182 patients with histologically confirmed CD who underwent MR enterography examination in ANONYMISED. For all patients, CD activity was interpreted by two independents, first based on abbreviated protocol (including T2-weighted imaging and balanced steady-state free precession (b-SSFP)) and then based on full protocol MRI. Agreement was assessed by concordance rates and Cohen's kappa. Results We found a high inter-modality agreement in CD activity assessment, with abbreviated non-contrast MRE demonstrating 98.4% concordance (179/182 cases) to contrast-enhanced MRE. Discordant findings (1.6%, 3/182) included one case misclassified as fibrostenotic and two as non-specific findings. Inter-reader agreement in MR enterography examination was also high (κ = 0.977 for final diagnosis, κ = 0.969 for fibrostenosis, and κ = 0.978 for comb sign detection), supporting high reproducibility between two radiologists. Conclusion Our findings demonstrate that abbreviated MR enterography (including T2-weighted sequence and b-SSFP) had substantial agreement with full protocol MR enterography in CD activity assessment, supporting its value as a reliable contrast-free alternative for practicing in clinical centers. Advances in knowledge Our investigation represents an advancement in CD imaging, leveraged by a large sample size, rigorous methodology, and comprehensive evaluation of different CD characterizations.

    2026
    引用
    AI阅读
    加入学术空间
    5Incidental Findings in Asymptomatic Healthy Individuals Screened with Total-Body Ultra-Low-Dose 18F-Fdg-pet/low-dose CT.
    Frederikke Engel Høi-Hansen,Christian Hinge,Helle Hjorth Johannesen,Elisabeth Albrecht-Beste, Christina Mikkelsen, Sisse Rye Ostrowski,Barbara Malene Fischer,Flemming Littrup Andersen,Kirsten Korsholm

    Abstract Objectives To evaluate the prevalence and clinical significance of incidental findings (IF) detected by Total-body 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in a genuinely asymptomatic cohort of blood donors. Methods 117 healthy, asymptomatic blood donors underwent ultra-low-dose FDG-PET/low-dose CT. The primary objective was to create an atlas of glucose metabolism in healthy individuals. A secondary objective was to assess the frequency and nature of IF, informing future considerations of the clinical value of potential screening programs. Here we report on IF. Results IF were detected in 64 participants (55%), with 51 (44%) presenting clinically insignificant IF and 13 (11%) clinically significant IF. Common insignificant IF included benign or inflammatory metabolic activity in the esophagus or lung parenchyma (n = 19), metabolically active reactive lymph nodes (n = 14), and degenerative skeletal changes (n = 13). Clinically significant IF comprised pathologically metabolically active cysts and polyps (n = 8), significantly enlarged vessels (n = 1), suspected malignant tumors (n = 1), large lipomas (n = 1), sarcoidosis (n = 1), and liver steatosis (n = 1). Conclusions This is the first study to systematically investigate incidental findings in an asymptomatic cohort using ultra-low-dose total-body FDG-PET/CT. Even in this highly selected population, numerous IFs were revealed, underscoring the need for risk-stratified, data-driven screening strategies integrating genetic biomarkers identifying individuals who will truly benefit. Advances in knowledge This first study of ultra-low-dose total-body FDG-PET/CT in asymptomatic donors found frequent incidental findings (55%, 11% clinically significant), establishing lower-bound estimates and supporting risk-stratified screening approaches.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 30886 篇论文

    高被引作者

    作者引用发文
    O. C. A. Scott309011
    AD CONGER30201
    Jack F. Fowler29874
    Vano Eliseo243340
    J Ambrose23194
    Eleanor Louise Wilkinson226616
    R. G. Dale224639
    Henry M. Smilowitz20972
    Toral Gathani20582
    B. F. Wall178823

    高产作者

    作者引用发文
    John W Hopewell169959
    Alan Jackson142451
    Gm Ardran146551
    J. A. Gleeson17150
    G.H. Whitehouse60146
    I. Isherwood80944
    T.J. Deeley45943
    K. Faulkner114742
    K. C. Dewbury128341
    George Wiernik88740

    相关期刊

    Clinical Radiology
    Journal of computer assisted tomography
    Radiographics
    Academic radiology
    Korean journal of radiology
    Japanese Journal of Radiology
    Diagnostic and Interventional Imaging
    Insights into Imaging
    European Journal of Radiology
    Radiologia Medica